Patient derived organoids in prostate cancer: improving therapeutic efficacy in precision medicine.

Mol Cancer · 2021 · PMC8480086 · PMID 34587953

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an encouraging trendno p-value reported

With the increased understanding of the origin and the molecular landscape of PCa, there has been an encouraging trend of precision medicine-based approach to treat advanced PCa.

also in 355 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.